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GP64, the major envelope glycoprotein of budded virions of the baculovirus Autographa californica multi-
capsid nucleopolyhedrovirus (AcMNPV), is involved in viral attachment, mediates membrane fusion during
virus entry, and is required for efficient virion budding. Thus, GP64 is essential for viral propagation in cell
culture and in animals. Recent genome sequences from a number of baculoviruses show that only a subset of
closely related baculoviruses have gp64 genes, while other baculoviruses have a recently discovered unrelated
envelope protein named F. F proteins from Lymantria dispar MNPV (LdMNPV) and Spodoptera exigua MNPV
(SeMNPV) mediate membrane fusion and are therefore thought to serve roles similar to that of GP64. To
determine whether F proteins are functionally analogous to GP64 proteins, we deleted the gp64 gene from an
AcMNPV bacmid and inserted F protein genes from three different baculoviruses. In addition, we also inserted
envelope protein genes from vesicular stomatitis virus (VSV) and Thogoto virus. Transfection of the gp64-null
bacmid DNA into Sf9 cells does not generate infectious particles, but this defect was rescued by introducing
either the F protein gene from LdMNPV or SeMNPV or the G protein gene from VSV. These results demon-
strate that baculovirus F proteins are functionally analogous to GP64. Because baculovirus F proteins appear
to be more widespread within the family and are much more divergent than GP64 proteins, gp64 may represent
the acquisition of an envelope protein gene by an ancestral baculovirus. The AcMNPV pseudotyping system
provides an efficient and powerful method for examining the functions and compatibilities of analogous or
orthologous viral envelope proteins, and it could have important biotechnological applications.
The baculoviruses are a large family of enveloped DNA
viruses that are pathogenic to invertebrates, infecting primarily
insects in the order Lepidoptera, but also certain members of
the Diptera and Hymenoptera (3, 9). Baculoviruses have super-
coiled, double-stranded DNA genomes of approximately 80 to
180 kbp. Baculoviruses are classified into two genera, the
nucleopolyhedroviruses (NPVs) and the granuloviruses (GVs),
and the NPVs can be further subdivided into groups I and II
based on phylogenetic studies of many genes (5, 11, 13).
GP64 is the major envelope protein of the budded-virus
(BV) form of group I NPVs such as Autographa californica
multicapsid nucleopolyhedrovirus (AcMNPV) and Orgyia
pseudotsugata MNPV (OpMNPV). GP64 is involved in viral
attachment and is required for low-pH-mediated membrane
fusion during virus entry (4, 12). GP64 is also required for
efficient budding of the BV (24). Thus, GP64 is required for
propagation of infection in cell culture and in Trichoplusia ni
larvae (22). Although GP64 proteins have been identified in
other group I NPVs, recent data from the complete genomic
sequences of a number of baculoviruses suggest that gp64
genes are not present in group II NPVs or GVs. An envelope
protein gene that is unrelated to gp64 was recently identified in
Lymantria dispar MNPV (LdMNPV) (27) and Spodoptera ex-
igua MNPV (SeMNPV) (15), and homologs of this gene have
been identified in other group II NPVs and GVs. This protein
has been named the F (fusion) protein (33). F proteins from
LdMNPV (ORF 130, or Ld130) and SeMNPV (ORF 8, or Se8)
are present in the virion membrane and mediate pH-triggered
membrane fusion (15, 27). Like envelope proteins from some
other virus groups, the baculovirus F proteins are cleaved in-
ternally by cellular proprotein convertases such as furin, and
cleavage is necessary for fusion activity (33). These observa-
tions suggest that F proteins may represent a functional analog
of GP64 in some (perhaps all) baculoviruses that do not have
a gp64 gene. To experimentally address this possibility, we
deleted the gp64 locus of a bacterial artificial chromosome
containing an AcMNPV genome (bacmid) (17) and inserted F
protein genes from two group II NPVs and a GV. We show
that the F protein genes from LdMNPV and SeMNPV can
rescue the gp64 knockout in AcMNPV. In addition, we show
that the predicted furin cleavage site present in the SeMNPV
F protein is required for processing of the SeMNPV F protein
and rescue of the gp64-null virus. We also examined the func-
tions of orthomyxovirus and rhabdovirus envelope proteins in
the gp64-null pseudotyping system.
MATERIALS AND METHODS
gp64-null AcMNPV bacmid. The gp64 gene of an AcMNPV bacmid
(bMON14272; Invitrogen) was deleted by using a modification of the method re-
ported by Bideshi and Federici (2). A chloramphenicol resistance gene (cat) cassette
was amplified by PCR with primers P5Spe(ChlR) (5-ACTAGTGCTGGATCGG
GCCCTAAATACCTG-3) and P3(ChlR)Bgl-II (5-AGATCTTTACGCCCCGC
CCTGCCACTCATC-3) and with plasmid pRE112 as a template (7). The PCR
product was cloned into the pCR-II-Blunt vector (Invitrogen) to generate plasmid
pChlR-CRIIblunt. The insert containing the cat cassette was excised from pChlR-
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CRIIblunt by SpeI and BglII digestion and was used to replace the SpeI-BglII
fragment (the gp64 gene) in pAcEcoHSma, a plasmid containing the AcMNPV
gp64 locus and flanking sequences (22). The resulting plasmid, pAcEcoHSma,gp64
(ChlR), was digested with EcoRI and HindIII; 60 ng of the gel-purified EcoRI-
HindIII fragment containing the cat cassette was cotransformed with 1 g of
bMON14272 into electrocompetent BJ5183 cells (Stratagene); and colonies re-
sistant to both kanamycin and chloramphenicol were selected.
Donor plasmids containing envelope protein genes. Genes (Ld130, Se8, Px26,
VSV-G, and gp75) encoding heterologous viral envelope proteins and AcMNPV
gp64 (as a positive control) were amplified by PCR using Vent DNA polymerase
(New England Biolabs) and cloned downstream of the AcMNPV gp64 promoter
on a modified pBacGus5 plasmid (Novagen), pmBG5. pmBG5 was modified by
digesting pBacGus5 with NcoI and SmaI to remove sequences encoding His tags
and protease cleavage sites. The 5 overhang was filled in with Klenow
fragment and religated, so that the AcMNPV gp64 early-plus-late promoter
was immediately upstream of a multiple cloning site and a -glucuronidase
gene (GUS) reporter driven by a p6.9 late viral promoter. As an example, the
AcMNPV gp64 open reading frame (ORF) was PCR amplified with primers
P5Bam2327Acgp64 (5-GGATCCAAGATGGTAAGCGCTATTGTTTT-
3) and P3AcEcoHdstopE (5-GAATTCTTAATATTGTCTATTACGGTTT
CTA-3) by using pAcEcoHSma as a template, digested with BamHI and
EcoRI, and cloned into similarly digested pmBG5. The gp64 promoter and
ORF were subsequently PCR amplified and subcloned into pFBgus(R), a
donor plasmid of pFastBac1 (Invitrogen) from which the polyhedrin promoter
had been removed and replaced with the GUS cassette from pBacGUS5.
Genes for heterologous envelope proteins were similarly amplified, cloned
into pmBG5, and subcloned into pFBgus(R). In some cases, genes (Ld130,
Px26, and gp75) were placed under the control of the stronger polyhedrin
promoter to increase expression. For the Px26, VSV-G, gp75, and Ld130
constructs under the control of the gp64 promoter, the p6.9 promoter-GUS
cassette was inserted in the orientation opposite that shown in Fig. 1 (with the
GUS transcription oriented toward Tn7R). All clones containing PCR-de-
rived sequences were confirmed by sequencing. To confirm expression of
Px26, sequences encoding a c-myc epitope tag were fused to the 3 end of the
Px26 ORF. Primers P5Px996 (5-GACCCTCGATTTCATGACGCTGTG-
3) and P3Px26cmycEcoRI (5-GTGAATTCCTACAGATCCTCTTCTGAG
ATGAGTTTTTGTTCCAGCGGTTTAAGTATCG-3) were used to amplify
the 3 end of Px26 and to add a c-myc epitope tag by PCR using pFBgusPx26
as a template. The PCR product was cloned into the pCR-4-Blunt vector
(Invitrogen), released by SacI and EcoRI, and used to replace the 3 end of
the Px26 gene in pFBgusPx26, generating plasmid pFBgusPx26c-myc.
Transpositions of inserts from donor plasmids into the gp64-null bacmid were
confirmed by gentamicin resistance, blue-white screening according to the BAC-
to-BAC manual (Invitrogen), and PCR using a primer corresponding to se-
quences in the GUS reporter gene in the donor plasmid (P-gus-jm [5-GTG
AAGAGTATCAGTGTGCATG-3]) in combination with a primer correspond-
ing to bacmid sequences adjacent to the transposition site (either the M13/pUC
forward primer [5-CCCAGTCACGACGTTGTAAAACG-3] or the M13/pUC
reverse primer [5-AGCGGATAACAATTTCACACAGG-3]).
Transfection-infection assay. DNAs were prepared from 1.5-ml cultures of 2
to 3 independent colonies carrying the bacmid with the inserted heterologous
envelope protein gene according to the BAC-to-BAC manual (Invitrogen) and
were analyzed in parallel. For transfections, 12.5% of each DNA preparation was
used to transfect 9  105 Sf9 or Sf9Op1D (28) cells in a 6-well plate by calcium
phosphate precipitation. At 72 h (protocol 1) or 10 days (protocol 2) posttrans-
fection, the supernatant (passage 1) was centrifuged for 10 min at 2,200  g to
remove debris, and this clarified supernatant (50 or 500 l) was used to infect 9
 105 Sf9 cells for 48 h (protocol 1) or 72 h (protocol 2). Both transfected and
infected cells were stained for GUS activity (according to the BAC-to-BAC
manual [Invitrogen]) to monitor transfection efficiency and to detect infection by
virions generated in transfected cells. Supernatants from infected Sf9 cells (pas-
sage 2) were stored at 4°C. In all cases where rescue was not observed by using
protocol 1, no rescue was observed by using protocol 2. As a control to confirm
that no lethal mutation had been acquired during propagation of the AcMNPV
bacmid in Escherichia coli, all bacmid DNAs were also used to transfect Sf9Op1D
cells (which express a GP64 protein) (28) and the supernatants from those
transfections were used to infect Sf9 cells.
Transfections into CHO cells were performed with Lipofectin (Invitrogen),
and 3 g of DNA was used to transfect 70% confluent cells in 60-mm plates
according to the manufacturer’s instructions.
Virus amplification and preparation. Viruses carrying envelope protein genes
that rescued the gp64-null phenotype were amplified by infecting one T150 flask
containing 107 Sf9 cells with 500 l of passage 2 supernatant, and cells were split
every 3 to 5 days for 10 to 13 days. Viruses carrying envelope proteins that did
not rescue the gp64 deletion were amplified in a similar manner but with Sf9Op1D
cells and Sf9Op1D cell-derived supernatant. Amplified pseudotyped viruses were
titered on Sf9Op1D cells by a TCID50 (50% tissue culture infective dose) assay
(25) and scored for infection by examining cells for GUS expression. Budded
virions were purified by centrifugation through a 25% sucrose pad, and Western
blot analysis was performed as described previously (20).
RESULTS
Disruption of the gp64 gene in an AcMNPV bacmid. The
critical roles that GP64 plays in AcMNPV budding and prop-
agation of infection were demonstrated by early physical and
functional studies (4, 12, 14, 16, 32) and by studies of gp64-null
viruses that were generated by homologous recombination in
insect cells (22, 24). To determine whether the recently iden-
tified baculovirus F proteins serve as functional analogs of
GP64 in baculoviruses with no gp64 gene, we modified an
AcMNPV bacmid (17) by first deleting the gp64 gene and then
inserting heterologous envelope protein genes. The gp64 gene
of the AcMNPV bacmid bMON14272 was deleted by homol-
ogous recombination in recA E. coli BJ5183 cells by using a
FIG. 1. (A) Strategy for generation of a gp64-null AcMNPV bac-
mid by homologous recombination in E. coli. The gp64 locus of the
AcMNPV bacmid (bMON14272) is shown above the EcoRI-HindIII
fragment that was used as a transfer vector to replace the gp64 locus
with a chloramphenicol resistance gene (cat). Sequences included for
homologous recombination (107325 to 108039 and 109761 to 112049)
are indicated (1). (B) Strategy for insertion of envelope protein gene
constructs into the polyhedrin locus of the gp64-null AcMNPV bacmid.
Inserts include a p6.9 promoter-GUS reporter and no envelope protein
gene (top) and a p6.9 promoter-GUS reporter plus envelope protein
genes (ENV) under the control of either the gp64 promoter (pGP64)
or the polyhedrin promoter (pPolh) (center). Envelope protein gene
cassettes were inserted into the att b site (indicated by right and left
insertion sites, Tn7R and Tn7L) in the polyhedrin locus by Tn 7-based
transposition. Envelope proteins and genes (italicized) are listed on
the right.
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linear EcoRI-HindIII fragment of DNA containing a cat cas-
sette flanked by 2,288 bp of sequences upstream, and 714 bp of
sequences downstream, of the gp64 locus (Fig. 1A). Three
colonies resistant to kanamycin and chloramphenicol were se-
lected and confirmed by PCR to contain the desired recombi-
nant gp64-null bacmid (data not shown). All three gp64-null
bacmids failed to propagate an infection after transfection into
Sf9 cells, while in parallel experiments, the original bacmid was
capable of initiating a spreading infection (data not shown).
gp64-null bacmid DNA was then transformed into DH10B
cells containing a helper plasmid (pMON7124) that encodes a
Tn7 transposase (17). The resulting E. coli strain (gp64 bac-
mid-DH10BpMON7124) was used to insert reporter and
envelope protein genes into the gp64-null bacmid for subse-
quent studies. To examine the abilities of several heterologous
envelope proteins to rescue the gp64-null AcMNPV, each het-
erologous envelope protein gene was inserted into the poly-
hedrin locus of the above gp64-null bacmid by using a donor
plasmid and Tn7-based transposition (17). Each donor plasmid
contained a GUS reporter gene plus the heterologous enve-
lope protein gene under the control of the AcMNPV gp64
promoter. In some cases, the envelope protein gene was also
placed under the control of the much stronger polyhedrin pro-
moter (Fig. 1B). As a positive control, the Ac MNPV gp64 gene
was inserted into a donor plasmid. A donor plasmid containing
no envelope protein gene served as a negative control. The
resulting bacmids were named vAcgp64 (no gp64 gene),
vAcgp64/Acgp64 (gp64 reinserted), and vAcgp64/env (“env”
stands for the heterologous envelope protein gene that was
inserted) (Fig. 1B).
Following the insertion of each heterologous envelope pro-
tein gene, bacmid DNAs from at least two independent colo-
nies were used to separately transfect Sf9 cells, and cells were
scored for the spread of infection and generation of infectious
virions by a transfection-infection assay (see Materials and
Methods). After transfection of Sf9 cells with each bacmid
construct, culture supernatants were harvested from trans-
fected cells at 72 h (or, alternatively, at 10 days) posttransfec-
tion and used to infect a second group of Sf9 cells, which were
incubated for 48 h (or, alternatively, for 72 h). If infectious
virions are produced from the transfected cells, infection
should be detected in the second group of cells. Both trans-
fected and infected cells were stained for GUS reporter activity
to detect entry and infection by the virus. Our results show that
although the gp64-null (vAcgp64) bacmid entered cells by
transfection and the late promoter was activated, infectious
virions were not produced and infection did not spread (Fig.
2C and D). In parallel experiments using the gp64-null bacmid
that was repaired by reinsertion of gp64 (vAcgp64/Acgp64), in-
fection spread in both transfected and infected cells (Fig. 2E
and F). Furthermore, transfection of the gp64-null bacmid into
Sf9Op1D cells (which express GP64) (28) also resulted in gen-
eration of infectious virions (Fig. 2K and L), indicating that the
defect can be rescued by supplying the GP64 protein in trans.
Thus, the inability of the gp64-null bacmid to propagate an
infection is due to the lack of GP64 and not to possible second-
site mutations.
Envelope proteins from group II NPVs rescue an AcMNPV
gp64-null bacmid. To determine whether F proteins from het-
erologous baculoviruses could rescue the gp64-null bacmid, we
placed three F protein genes under the control of the AcMNPV
gp64 promoter and inserted each construct into the gp64-null
bacmid (Fig. 1B and Table 1). Transfection of Sf9 cells with
gp64-null bacmids carrying the F protein gene from SeMNPV
or LdMNPV resulted in rescue of the gp64-null AcMNPV and
production of infectious virions (Fig. 2G and H; Table 1,
vAcgp64/Se8 and vAcgp64/Ld130). In contrast, the gp64-null
bacmid carrying the F protein gene from the Plutella xylostella
GV (PxGV) (Table 1, vAcgp64/Px26) (10) did not produce
infectious virions. To ensure that the PxGV F protein can be
expressed in Sf9 cells, a bacmid containing sequences encoding
the PxGV F protein with a c-myc epitope tag (vAcgp64/Px26c-myc)
was generated. After transfection of the vAcgp64/Px26c-myc bac-
mid into Sf9 cells, the c-myc-tagged PxGV F protein was de-
FIG. 2. Transfection-infection assay for viral propagation. Sf9 cells were transfected with the indicated bacmids, incubated for 72 h, and stained
for GUS activity (A, C, E, and G). Supernatants from the transfected cells (top panels) were used to infect Sf9 cells (B, D, F, and H), which were
incubated for 48 h and then stained for GUS activity. Staining of cells in the lower panels (infected cells) indicates that infectious virions were
generated in the transfected cells. Bacmids that fail to propagate an infection in Sf9 cells can propagate an infection in cells expressing OpMNPV
GP64 (Sf9Op1D). Sf9Op1D cells were transfected with the indicated bacmids (I, K, and M) and incubated for 72 h; then supernatants were
transferred to Sf9 cells and stained for GUS activity after 48 h (J, L, and N).
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tected by Western blot analysis of infected cell lysates (data not
shown), indicating that the PxGV F protein could be ex-
pressed. However, neither the wild-type nor the c-myc-tagged
PxGV F protein rescued gp64-null AcMNPV, suggesting that
PxGV F was unable to substitute for GP64 function. To de-
termine whether a stronger promoter driving expression of the
PxGV F protein could result in rescue of the gp64 deletion, we
tested a gp64-null bacmid containing the Px26 gene under the
control of the polyhedrin promoter (vAcgp64/pPolh-Px26). Al-
though a parallel LdMNPV F gene construct (under polyhedrin
promoter control) complemented GP64 function, the PxGV F
gene construct did not (Table 1). When both bacmids encoding
Px26 were transfected into Sf9Op1D cells, infectious virions
were produced (Table 1), indicating that the lack of virion
production in Sf9 cells was due to lack of a functional envelope
protein and not to a second-site mutation. Thus, our results
show that the F protein genes from LdMNPV and SeMNPV
rescued a gp64-null bacmid, but the F protein gene from PxGV
did not.
Thogoto virus GP75 is incorporated into AcMNPV virions
but does not rescue a gp64-null bacmid. Two envelope proteins
from viruses unrelated to baculoviruses were also examined in
these studies: vesicular stomatitis virus (VSV) G protein and
Thogoto virus GP75. VSV-G shows no sequence similarity to
either GP64 or F proteins but was included as a positive con-
trol, since a previous study showed that it was able to rescue a
gp64 deletion (20). In agreement with the findings of that
study, the VSV G gene rescued the gp64 deletion in AcMNPV
(Table 1). Although the Thogoto virus is a single-stranded
RNA virus (orthomyxovirus), the Thogoto virus GP75 enve-
lope protein shares 28% amino acid sequence identity with the
AcMNPV GP64 protein and therefore appears to be derived
from a common ancestor (23). We therefore asked whether
GP75 could rescue a gp64-null AcMNPV bacmid. The Thogoto
virus gp75 gene, under the control of either the gp64 promoter
or the polyhedrin promoter, failed to rescue the gp64 deletion
in AcMNPV (Table 1). Expression of Thogoto virus GP75 in
transfected Sf9 cells and the presence of GP75 in pseudotyped
virions were confirmed by Western blot analysis (Fig. 3A and
B). Moreover, when Sf9Op1D cells were transfected with either
the vAcgp64/Thogp75 or the vAcgp64/pPolh-Thogp75 bacmid, the
TABLE I. Pseudotyped gp64-null bacmids and viruses
gp64-null bacmid Envelope protein Promoter Rescue
Titer (IU/ml)a in:
Sf9 cells Sf9Op1D cells
Controls
vAcgp64 None  NA 8.3  106
vAcgp64/Acgp64 AcMNPV GP64 gp64  2.9  108 ND
Baculovirus F proteins
vAcgp64/Se8 SeMNPV F gp64  2.5  107 ND
vAcgp64/Se8K149 SeMNPV FK149 gp64  NA 2.2  10
7
vAcgp64/Ld130 LdMNPV F gp64  5.0  106 8.3  106
vAcgp64/pPolh-Ld130 LdMNPV F polyh  8.3  104 6.9  104
vAcgp64/Px26 PxGV F gp64  NA 1.9  106
vAcgp64/pPolh-Px26 PxGV F polyh  NA 1.4  107
Other viral Env proteins
vAcgp64/VSV-G VSV G gp64  5.9  107 ND
vAcgp64/Thogp75 Thogoto GP75 gp64  NA 2.8  106
vAcgp64/pPolh-Thogp75 Thogoto GP75 polyh  NA ND
a NA, not applicable; ND, not determined.
FIG. 3. Thogoto virus GP75 protein expression, detection in
AcMNPV budded virions, and membrane fusion activity. (A) Western
blot analysis of GP75 expression in Sf9 cells that were either mock
transfected (lane 1) or transfected with the vAcgp64/Thogp75 (lane 2) or
vAcgp64 (lane 3) bacmid and examined at 72 h posttransfection. GP75
was detected by using an affinity-purified antibody generated against a
GP75 peptide (N-KERAHEKSKDLPFGNK-C). (B) Western blot de-
tection of GP75 protein in purified budded virions (vAcgp64 or
vAcgp64/Thogp75) generated in Sf9Op1D cells. An anti-capsid protein
(VP39) antibody was used as an internal control (lower panel). (C and
D) Syncytium formation assay. CHO cells were transfected with a
plasmid (pRC-THO) expressing GP75 under the control of a cytomeg-
alovirus early promoter. At 24 h posttransfection, cells were incubated
in phosphate-buffered saline at pH 7.0 (C) or pH 5.0 (D) for 15 min;
then they were examined for syncytium formation after 90 min. Large
syncytial masses containing many nuclei are indicated by arrowheads.
Cells transfected with the empty vector (pRC-CMV) did not show
syncytium formation (data not shown).
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virus could be propagated (Table 1), confirming that the bac-
mid was otherwise replication competent. Because Thogoto
virus GP75 was expressed in infected Sf9 cells and can be
incorporated into AcMNPV budded virions, these results sug-
gest that Thogoto virus GP75 is not able to functionally sub-
stitute for GP64 in the context of an AcMNPV infection. To
determine whether GP75 was functional in Sf9 cells, we per-
formed a membrane fusion (syncytium formation) assay in Sf9
cells, using the donor plasmid construct that expresses GP75
under the control of the AcMNPV gp64 promoter. Transiently
expressed GP75 did not mediate detectable low-pH-triggered
membrane fusion (data not shown). Since Thogoto virus is a
tick-borne virus that replicates in a variety of mammals (6), we
also tested GP75 for syncytium formation in mammalian cells.
When GP75 was expressed in CHO cells and similarly assayed,
pH-triggered membrane fusion was readily detected (Fig. 3C
and D). Thus, GP75 mediated membrane fusion in mammalian
cells but did not appear to be functional in insect Sf9 cells. This
may explain the inability of GP75 to rescue the gp64-null bac-
mid.
Infectious virion production by pseudotyped viruses. To
more thoroughly characterize the ability of certain envelope
proteins to substitute for GP64 in pseudotyped gp64-null vi-
ruses, we performed one-step growth curves. Infectious virus
production from the repair virus (containing wild-type gp64
reinserted into the polyhedrin locus) was similar to that from
wild-type AcMNPV (Fig. 4), indicating that the use of the
bacmid itself and the introduction of envelope genes into the
polyhedrin locus did not have a significant negative effect on
infectious virion production. Virus production by the VSV-G-
pseudotyped virus was approximately 1 log unit lower than that
by the wild-type AcMNPV (Fig. 4). Virus production by viruses
pseudotyped with the F protein from either SeMNPV or
LdMNPV was approximately 2 log units lower than that by
control viruses (Fig. 4). The presence of VSV-G and SeMNPV
F proteins in purified budded virions was also confirmed (Fig.
5, lanes 1 and 2). Although Ld130 antibodies were not avail-
able, the GP64-null phenotype was confirmed (Fig. 5, lane 3),
and the genotypes of all viruses were confirmed by PCR anal-
ysis (data not shown).
Proteolytic cleavage of the SeMNPV F protein is essential
for rescue of the gp64-null bacmid. Recently, a proprotein
convertase (PPC or furin) cleavage site was identified in a
number of baculovirus F proteins (15). The consensus furin
cleavage site [R-X-(R/K)-R] is conserved at a similar position
in F proteins from group II NPVs and GVs. Recent biochem-
ical and mutagenic studies of the SeMNPV F protein strongly
suggested that the SeMNPV F protein is cleaved by a PPC or
furin protease (33). To determine whether cleavage at the
furin cleavage site is essential for rescue of the gp64-null virus
by the SeMNPV F protein, we generated a gp64-null bacmid
expressing a SeMNPV F protein with a point mutation in the
furin cleavage site (Se8K149) (Fig. 6A). This point mutation, an
arginine-to-lysine substitution in a critical residue in the con-
sensus furin cleavage site, was previously shown to prevent F
protein cleavage (33). Using two protocols for testing gp64
complementation, we found that the F protein containing the
Se8K149 mutation did not complement the gp64-null bacmid
(see Table 1). However, the Se8K149-pseudotyped virus can be
propagated in Sf9Op1D cells, and titers of approximately 2  107
IU/ml can be achieved in these cells (Table 1, vAcgp64/Se8K149).
Western blot analysis of Se8K149-pseudotyped virions shows
that Se8K149 can be detected in these preparations (Fig. 6B,
lane 3), indicating that Se8K149 can be incorporated into the
FIG. 5. Western blot analysis of pseudotyped virions. A series
of Western blots of purified virions from pseudotyped viruses
vAcgp64/VSV-G (lane 1), vAcgp64/Se8 (lane 2), and vAcgp64/Ld130 (lane
3) were probed with antibodies -Se8 (against SeMNPV F1 protein,
the 60-kDa Se8 cleavage product) (33), -VSV-G (20), and -GP64
(monoclonal antibody AcV5) (14). An anti-nucleocapsid antibody (-
VP39) was used as an internal control for each preparation of purified
budded virions (20). GP64 was not detected from pseudotyped viruses
but was detected in a positive control shown on the right (Sf9 cell
lysates infected with the repair virus, vAcgp64/Acgp64). Positions of
uncleaved and cleaved SeMNPV F are indicated.
FIG. 4. One-step growth curves are shown for wild type AcMNPV,
the repair virus vAcgp64/Acgp64, and AcMNPV gp64-null viruses
pseudotyped with VSV-G (vAcgp64/VSV-G), Se8 (vAcgp64/Se8), or
Ld130 (vAcgp64/Ld130). Sf9 cells were infected at a multiplicity of
infection of 5, and supernatants were harvested at the indicated times
postinfection and titered on Sf9Op1D cells. Each data point represents
the average from three separate infections (error bars, standard devi-
ations), except for the data point for the Se8-pseudotyped virus at
168 h postinfection, which represents a single infection.
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virion. In these preparations, Se8K149 was detected as a protein
of approximately 75 kDa. In contrast, a 60-kDa processed form
of F (Se8) was the major protein form detected in virions
pseudotyped with the wild-type SeMNPV F protein (Fig. 6B,
lane 1) and in wild-type SeMNPV virions (15). These results
demonstrate that the putative furin cleavage site is necessary
both for processing of this F protein and for complementation
of the gp64-null virus in Sf9 cells.
DISCUSSION
The GP64 envelope protein is necessary for the critical first
steps (attachment and entry) and the essential final steps (as-
sembly and budding) in the infection cycle of AcMNPV. In this
study, we examined functional similarities between GP64 and
the recently discovered baculovirus F proteins. We show that
an AcMNPV gp64-null virus can be rescued by F proteins from
LdMNPV and SeMNPV (group II NPVs). The gp64-null vi-
ruses pseudotyped with F proteins from LdMNPV and
SeMNPV generated substantially lower virus titers than wild-
type AcMNPV. This suggests that the degree of compatibility
between these F proteins and other AcMNPV or host proteins
may not be optimal. Such incompatibilities might result in (i)
inefficient virion budding, (ii) inefficient virus binding to host
cell receptors, or (iii) inefficient membrane fusion and virus
release from endosomes during virus entry. In spite of the
differences in efficiency, these F proteins were able to substi-
tute at least partially for all of the essential functions of GP64
and resulted in the production of infectious viruses. Thus, F
proteins are functionally analogous to GP64. In contrast to the
F protein genes from SeMNPV and LdMNPV, the PxGV gene
did not rescue the gp64-null AcMNPV. Although it is possible
that the PxGV F protein was inefficiently expressed, we believe
this is unlikely because both the LdMNPV and SeMNPV F
proteins were expressed in quantities sufficient to rescue the
gp64-null bacmid, and expression of an epitope-tagged PxGV F
protein was detected (data not shown). Therefore, we specu-
late that the inability of the PxGV F protein gene to rescue the
gp64-null AcMNPV may be related to the greater evolutionary
distance between AcMNPV and PxGV, resulting in less-com-
patible interactions between the F protein and other AcMNPV
or host cell proteins. Consistent with this hypothesis, LdMNPV
and SeMNPV F proteins are similar in length (676 and 665
amino acids, respectively) and more highly conserved (38%
identity), whereas the PxGV F protein is only 544 amino acids
long, and the PxGV and LdMNPV F proteins are only 24%
identical. Thus, our results from pseudotyping experiments
with heterologous F proteins suggest that functional comple-
mentation reflects evolutionary distance.
It is of special interest that group I NPVs such as AcMNPV
and OpMNPV (which carry gp64 genes) also have genes en-
coding F protein homologs (Ac23 and Op21, respectively).
One hypothesis to explain the existence of two different but
functionally similar envelope proteins (GP64 and F proteins)
within the family Baculoviridae, plus the presence of both
GP64 and F protein homologs in certain group I NPVs, is the
possibility that gp64 is a recent acquisition by an ancestor of the
group I NPVs (29). In this scenario, many or most of the
functions of the ancestral AcMNPV F protein homolog may
have been replaced by the GP64 protein, thus releasing all or
portions of the AcMNPV F protein homolog from selection
pressure. Consistent with this hypothesis, AcMNPV and
OpMNPV F protein homologs appear to be less well conserved
than F proteins from group II NPVs and GVs. Even though
group I and II NPVs are more closely related phylogenetically
(13), the AcMNPV F protein (Ac23) and the LdMNPV F
protein (Ld130) are only 13% identical. In contrast, the
LdMNPV and PxGV F proteins are approximately 24% iden-
tical (29). In addition, the essential furin cleavage site that is
present in LdMNPV and SeMNPV F proteins is absent in the
predicted Ac23 and Op21 proteins. Furthermore, while F pro-
teins from group II NPVs can functionally replace AcMNPV
GP64, the F protein homolog of AcMNPV (Ac23) cannot
compensate for a gp64 deletion in AcMNPV (22, 24). While F
proteins from group II NPVs and GVs likely serve an essential
role in infectivity, the function of the more divergent F protein
homologs in group I NPVs remains unknown. However, the
observation that AcMNPV and OpMNPV F gene homologs
are intact ORFs suggests that they may provide a beneficial
function. Consistent with this hypothesis, Pearson et al. (27a)
recently reported that the OpMNPV F homolog (Op21) is
expressed and colocalized with GP64 in the budded virion
FIG. 6. (A) Diagram of the furin cleavage site in the SeMNPV F
protein (Se8) and the Se8K149 mutant. RSKR represents the furin
cleavage site in the wild-type SeMNPV F protein (Se8), and RSKK
represents the furin cleavage site containing a single amino acid sub-
stitution (Se8K149). (B) Western blot analysis of gp64-null budded
virions pseudotyped with Se8 or Se8K149. Virion preparations (lanes 1
to 3) were probed with antibodies directed against the SeMNPV F
protein (-Se8), GP64 (-GP64), and VP39 (-VP39). Virions of
vAcgp64/Se8 were generated in infected Sf9 cells (lane 1), whereas
virions of vAcgp64 (lane 2) and vAcgp64/Se8K149 (lane 3) were gener-
ated in infected Sf9Op1D cells. The latter virions therefore contain Op
MNPV GP64 (lanes 2 and 3). The VP39 capsid protein was included as
an internal control. Positions of cleaved and uncleaved forms of Se8
are indicated.
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membrane. Baculovirus F protein homologs were also recently
identified in a subgroup of apparent retroviruses. This sub-
group, referred to as insect errantiviruses (19), appears to have
evolved from invertebrate long terminal repeat-containing ret-
rotransposons that acquired an envelope protein gene, to be-
come infectious retroviruses (30, 31). The envelope protein
genes of the Ty3/Gypsy group of retrotransposons from Dro-
sophila melanogaster and the TED retrotransposon from T. ni
(26) are homologs of the baculovirus F protein genes, and it
has recently been suggested (19) that these invertebrate retro-
transposons acquired their envelope protein gene from a bac-
ulovirus. In addition, a possible cellular homolog of the bacu-
lovirus F protein gene has been identified in Drosophila (29).
Exchange of genetic material is known to occur between bacu-
loviruses and their hosts, and also between coinfecting bacu-
loviruses (8, 18, 21). A recent study by Herniou et al. (13)
suggested that baculovirus genomes were highly fluid, with
gene rearrangements and multiple gene content changes oc-
curring during their evolution. Of 17 genes that are thought to
be unique to group I NPVs, 4 encode structural proteins (13).
Thus, gp64 and possibly other structural protein genes in group
I NPVs may represent gene acquisitions from the host or from
other viruses. The acquisition of new envelope proteins repre-
sents a mechanism by which some viruses are known to en-
hance their fitness. For example, orthomyxoviruses use reas-
sortment to increase their diversity, and the acquisition of new
envelope protein genes permits them to avoid immune detec-
tion. Although it is not clear if or why GP64 would provide a
selective advantage, we might speculate that acquisition of
GP64 could have increased the efficiency of virus-receptor
interactions, virus entry, or virus budding. Alternatively, GP64
may have facilitated the recognition of a different host cell
receptor(s) and increased the range of cells or tissues infected.
Thus, acquisition of this gene may have resulted in either more
productive infections, or an increase or change in cell types
infected.
In addition to F proteins, we also asked whether GP75 from
Thogoto virus could functionally complement GP64. The fact
that Thogoto virus GP75 shows 28% amino acid sequence
identity to AcMNPV GP64 (23) is striking and suggests that
GP64 and GP75 proteins have a common evolutionary origin,
even though orthomyxoviruses and baculoviruses do not ap-
pear to share a common evolutionary origin. Since Thogoto
virus is vectored to mammals by arthropods (ticks), an intrigu-
ing possible scenario is that an ancestor of the Thogoto virus
acquired a GP64 homolog either from the arthropod host
genome or from a host coinfected with a baculovirus (23).
However, other possible scenarios cannot be eliminated. Since
it is likely that the GP64 and GP75 proteins have a common
evolutionary origin, we asked in the present study whether
GP75 could substitute for GP64 in AcMNPV. We found that
GP75 was expressed and appropriately transported in infected
Sf9 cells, and GP75 was also found in pseudotyped virions.
However, GP75 did not rescue the gp64-null AcMNPV. In
subsequent experiments we were unable to detect membrane
fusion activity in Sf9 cells expressing GP75, while, in contrast,
GP75 mediated membrane fusion in mammalian CHO cells.
These observations suggest that while GP75 and GP64 share
functional similarity (i.e., they are both membrane fusion pro-
teins), GP75 may be somehow incompatible with the Sf9 host
cells or with the AcMNPV entry or budding apparatus. This
incompatibility may reflect GP64 and GP75 adaptations to the
different host and viral systems.
In summary, we have developed and used a versatile genetic
system to examine the function and compatibility of heterolo-
gous envelope protein genes in the context of an AcMNPV
baculovirus infection. Using this system, we demonstrated that
F proteins from group II NPVs can rescue infectivity and
budded virus production in the absence of gp64. We also found
that Thogoto virus GP75 did not substitute for GP64 in
AcMNPV, although the two proteins share 28% amino acid
identity. In contrast, the unrelated but highly promiscuous
VSV G protein effectively rescued a gp64-null AcMNPV. The
bacmid-based pseudotyping system developed for these studies
will be useful for future studies aimed at understanding the
nature of envelope protein interactions necessary for efficient
entry and budding, and for pseudotyping AcMNPV for poten-
tial medical and biotechnological applications. Examples of
such applications might include pseudotyping AcMNPV with
modified envelope proteins in order to modulate the host
range of AcMNPV as a biocontrol agent, or to target specific
cells or tissues for efficient or restricted delivery of genes for
insect transgenesis or for gene therapy.
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